|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Cancer-Related Problem/Condition | |||||
| Fatigue | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Weight Loss | |||||
| 3 | More general conditions related to this trial | ||||
| Body Weight | |||||
| Body Weight Changes | |||||
| Signs and Symptoms | |||||
| 4 | Interventions listed in this trial | ||||
| megestrol acetate | |||||
| physical therapy | |||||
| 5 | Additional drug interventions recognized in this trial | ||||
| Megestrol | |||||
| 6 | More general drug interventions related to this trial | ||||
| Antineoplastic Agents | |||||
| Antineoplastic Agents, Hormonal | |||||
| Appetite Stimulants | |||||
| Central Nervous System Agents | |||||
| Central Nervous System Stimulants | |||||
| Contraceptive Agents | |||||
| Contraceptive Agents, Female | |||||
| Contraceptives, Oral | |||||
| Contraceptives, Oral, Synthetic | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| Reproductive Control Agents | |||||
| Therapeutic Uses | |||||
| 7 | Sponsors listed in this trial | ||||
| Robert H. Lurie Cancer Center | |||||
| National Cancer Institute (NCI) | |||||